DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C0020501 | Primary Hyperoxaluria | HAO1 | 54363 | hydroxyacid oxidase 1 | Q9UJM8 |
C1833683 | NEPHROLITHIASIS, CALCIUM OXALATE | HAO1 | 54363 | hydroxyacid oxidase 1 | Q9UJM8 |
C0022650 | Kidney Calculi | HAO1 | 54363 | hydroxyacid oxidase 1 | Q9UJM8 |
C0020500 | Hyperoxaluria | HAO1 | 54363 | hydroxyacid oxidase 1 | Q9UJM8 |
C0392525 | Nephrolithiasis | HAO1 | 54363 | hydroxyacid oxidase 1 | Q9UJM8 |
C0376358 | Malignant neoplasm of prostate | HAO1 | 54363 | hydroxyacid oxidase 1 | Q9UJM8 |
C3888018 | Congenital Hyperinsulinism | HAO1 | 54363 | hydroxyacid oxidase 1 | Q9UJM8 |
C0025521 | Inborn Errors of Metabolism | HAO1 | 54363 | hydroxyacid oxidase 1 | Q9UJM8 |
C0020456 | Hyperglycemia | FBXO2 | 26232 | F-box protein 2 | Q9UK22 |
C0024623 | Malignant neoplasm of stomach | FBXO2 | 26232 | F-box protein 2 | Q9UK22 |
C0030567 | Parkinson Disease | FBXO2 | 26232 | F-box protein 2 | Q9UK22 |
C0003873 | Rheumatoid Arthritis | FBXO2 | 26232 | F-box protein 2 | Q9UK22 |
C0699791 | Stomach Carcinoma | FBXO2 | 26232 | F-box protein 2 | Q9UK22 |
C0002395 | Alzheimer's Disease | FBXO2 | 26232 | F-box protein 2 | Q9UK22 |
C0086648 | MPS III B | NAGPA | 51172 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Q9UK23 |
C0038506 | Stuttering | NAGPA | 51172 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Q9UK23 |
C2673377 | MUCOLIPIDOSIS II ALPHA/BETA (disorder) | NAGPA | 51172 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Q9UK23 |
C0476254 | Dyslexia | NAGPA | 51172 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Q9UK23 |
C0920296 | Developmental reading disorder | NAGPA | 51172 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Q9UK23 |
C0033788 | Pseudo-Hurler Polydystrophy | NAGPA | 51172 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Q9UK23 |
C0524851 | Neurodegenerative Disorders | NAGPA | 51172 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Q9UK23 |
C0026697 | Mucolipidoses | NAGPA | 51172 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Q9UK23 |
C0027651 | Neoplasms | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0024299 | Lymphoma | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
C0549473 | Thyroid carcinoma | PARP4 | 143 | poly(ADP-ribose) polymerase family member 4 | Q9UKK3 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024